Wiltrom Co. Ltd. · TPEX:6767

Wiltrom — Investor Presentation (October 2025)

17 slides from Wiltrom's investor presentation, October 2025

  1. Slide 1: Wiltrom Co., Ltd

    Stock Number: 6767 Wiltrom Co., Ltd 0

  2. Slide 2: Safe Harbor Notice

    Safe Harbor Notice Except for historical information set forth herein, this presentation contains certain forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from what may be expressed or implied by such statements. Investors sh

  3. Slide 3: Outline

    Outline I. Company profile II. Product introduction III. Description of operating conditions VI. Business development strategy and future prospects 2

  4. Slide 4: Company profile

    Company profile Stock Num: 6767 Company Name Wiltrom Co., Ltd Establish Date 2009/12/18 1F., No.26, Sec. 2, Shengyi Rd., Zhubei City, Address Hsinchu County, 30261, Taiwan (R.O.C.) +886 3 6107168 Capital NTD$ 291,090,000 President &General Dr. Huang-Chien Liang Manager: Spinal Fixation System, Inter

  5. Slide 5: Milestone

    Milestone 2018 2021 2014 2019 2009 2016 The first Taiwanese brand company get TFDA approval of First Taiwan spine private Spine Minimally label enters US market OTC-listed company Invasive fixation First to develop patented system technology "Vertebral Body ITRI Technology Extension Augmentation Sys

  6. Slide 6: Management team

    Management team President&General Manager Operation Management Ministry of Law Research and Development General Administration Department, Director Department, Director Department, Manager Department, Manager PHD. Huang-Chien Jack Su Terry Tsai PHD. Hung-Ying, Tai Jessica Hsiao Liang 5

  7. Slide 7: Outline

    Outline I. Company profile II. Product introduction III. Description of operating conditions VI. Business development strategy and future prospects 6

  8. Slide 8: Product Portfolio

    Product Portfolio Vertebral Compression Spinal fusion surgery Frx. Surgery Bone Cement ⚫ Spinal Fixation System ⚫ Vertebral ⚫ Bone Cement Augmentation System ⚫ Interbody Fusion System ⚫ Bone Graft Substitute 7

  9. Slide 9: Innovative product presentation

    Innovative product presentation Spinal Fixation System Vertebral Augmentation System Tripod-Fix Before Expansion(mm) After Expansion(mm) ➢ Small wounds, low blood loss, shorter hospital stay. ➢ Versatile design for a variety of minimally ➢ The only expandable system designed for invasive procedures.

  10. Slide 10: Outline

    Outline I. Company profile II. Product introduction III. Description of operating conditions VI. Business development strategy and future prospects 9

  11. Slide 11: Q1-Q3/2022 Financial results

    Q1-Q3/2022 Financial results (In Thousands of New Taiwan Dollars) GROW54.8% ACCOUNT Q1~Q3/2021 Q1~Q3/2022 DIFF YOY OPERATING REVENUE 98,836 152,979 54,143 54.8% NET OPERATING INCOME(LOSS) (26,391) (5,948) 20,443 -77.5% NON-OPERATING INCOME AND EXPENSES (18,917) (5,796) 13,121 -69.4% LOSS FROM CONTIN

  12. Slide 12: Operating revenue & Gross margin

    Operating revenue & Gross margin (In Thousands of New Taiwan Dollars) 11

  13. Slide 13: Revenue Breakdown (2021 vs. 2022)

    Revenue Breakdown(2021 vs. 2022) Q1-Q3,21 Q1~Q3'22 foreign foreign $6,599,263 (7%) $15,414,860 (10%) Taiwan Taiwan $92,236,551 (93%) $134,499,457 (90%) Currency:NTD ➢ For Taiwan revenue, compared to last year, $42,262,941, 46% YoY. ➢ For Foreign revenue, compared to last year, $8,815,562, 134% YoY.

  14. Slide 14: Global Revenue Statistics (2021 vs. 2022)

    Global Revenue Statistics(2021 vs. 2022) Q1~Q3'21 Q1~Q3'22 Other6% YoY -14% Other 17% SEA12% China 27% China 28% YoY 541% YoY 128% SEA4% USA 34% EU 21% YoY 55% New markets USA 51% ➢ Compared to last year, 2022 YoY Strong revenue growth were driven by new clients, including EU, SEA, USD, China. 13

  15. Slide 15: Outline

    Outline I. Company profile II. Product introduction III. Description of operating conditions VI. Business development strategy and future prospects 14

  16. Slide 16: Business Strategy

    Business Strategy ➢ Taiwan Market: 2023 growth is expected to be growing with new hospitals exploitation and increased product usage. ➢ EU Market: To create market penetration through a new product Tripod-fix. Tripod-fix growth serves as structural support for sales growth drivers in 2023. ➢ SEA Mar

  17. Slide 17: Thanks for your attention

    Thanks for your attention > . WUTEEFOM sec: sestn enn

Wiltrom — Investor Presentation (October 2025) on 6ix